论文部分内容阅读
目的 了解淋病及非淋菌性尿道炎(NGU)患者病原微生物感染状况及药物疗效情况.方法 分析了200例淋病及NGU患者的病原学状况,并对几种药物治疗及NGU的疗效进行了观察.结果 单纯淋球菌感染者34例(17%),解脲支原体感染为39例(19．5%),衣原体为65例(32．5%),混合性感染为53例(26．5%),念珠菌感染为9例(4．5%).淋病患者经头孢三嗪治疗后,淋球菌的转阴率明显高于淋必治(P＜0．01).NGU患者经阿奇霉素治疗后的转阴率略高于罗红霉素(P＞0．05).结论 NGU的发病率正以较快的速度上升.青霉素、淋必治的耐药率正在逐渐升高.
Objective To investigate the status of pathogenic microorganisms and drug efficacy in patients with gonorrhea and non-gonococcal urethritis (NGU) .Methods The etiology of 200 cases of gonorrhea and NGU were analyzed and the effects of several drug treatments and NGU were observed. RESULTS: Thirty-four (17%) patients were diagnosed with gonococcal infection, 39 (19.5%) were ureaplasma urealyticum, 65 (32.5%) were chlamydia, and 53 (26.5%) were mixed infections , Candida infection was 9 cases (4.5%). After gonorrhea treatment in gonorrhea patients, the gonorrhea rate of gonococci was significantly higher than that of gingivalis (P0.01) .NGU patients after treatment with azithromycin (P0.05) .Conclusion The incidence of NGU is increasing at a faster rate.The rate of resistance to penicillin and Dianbaci is gradually increasing.